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Defective Acetylcholine Receptor 
Subunit Switch Precedes Atrophy 
of Slow-Twitch Skeletal Muscle 
Fibers Lacking ERK1/2 Kinases in 
Soleus Muscle
Shuo Wang*, Bonnie Seaberg*, Ximena Paez-Colasante† & Mendell Rimer
To test the role of extracellular-signal regulated kinases 1 and 2 (ERK1/2) in slow-twitch, type 1 skeletal 
muscle fibers, we studied the soleus muscle in mice genetically deficient for myofiber ERK1/2. Young 
adult mutant soleus was drastically wasted, with highly atrophied type 1 fibers, denervation at most 
synaptic sites, induction of “fetal” acetylcholine receptor gamma subunit (AChRγ), reduction of 
“adult” AChRε, and impaired mitochondrial biogenesis and function. In weanlings, fiber morphology 
and mitochondrial markers were mostly normal, yet AChRγ upregulation and AChRε downregulation 
were observed. Synaptic sites with fetal AChRs in weanling muscle were ~3% in control and ~40% in 
mutants, with most of the latter on type 1 fibers. These results suggest that: (1) ERK1/2 are critical for 
slow-twitch fiber growth; (2) a defective γ/ε-AChR subunit switch, preferentially at synapses on slow 
fibers, precedes wasting of mutant soleus; (3) denervation is likely to drive this wasting, and (4) the 
neuromuscular synapse is a primary subcellular target for muscle ERK1/2 function in vivo.
Developmental switches in the subunit composition of ligand-gated ion channels that serve as neurotransmitter 
receptors at glutamatergic, gabaergic, and cholinergic synapses are important for structural and functional syn-
aptic maturation throughout the nervous system. The subunit composition of acetylcholine receptors (AChRs) in 
the postsynaptic apparatus at developing neuromuscular junctions (NMJ) in the mammalian embryo is α 2β γ δ . 
As the synapses mature neonatally, these “fetal” AChRs are gradually replaced by “adult” receptors composed of 
α 2β δ ε , which have different channel conductance properties1,2. Germline deletion of Chrne3–5, the gene encoding 
AChRε , yields mice that survive embryonic development but harbor NMJs with much lower AChR density that 
retain AChRγ . These animals have defective neuromuscular transmission, display gradual muscle weakness and 
atrophy, and die by 2–3 months after birth. Thus the γ /ε -AChR subunit switch is essential for normal skeletal 
muscle development.
Extracellular signal-regulated kinases 1 and 2 (ERK1/2), the prototypical mitogen-activated protein kinases, 
mediate a multitude of responses to growth factors and cytokines in cellular proliferation, differentiation, senes-
cence, apoptosis, and survival6. ERK1/2 have been implicated in the maintenance of adult skeletal muscle mass7 
and, seemingly paradoxically, in the control of both the fast-twitch (type 2)8 and the slow-twitch (type 1)9 fiber 
type phenotypes. Previously10, we generated mice genetically deficient in myofiber ERK1/2. These animals sur-
vived development but displayed stunted postnatal growth, muscle weakness and shorter lifespan. We studied 
two fast-twitch muscles in young adult mice, the sternomastoid (STN) and the tibialis anterior (TA), and found 
that in both mutant muscles NMJs became fragmented and had reduced AChRε expression. In STN, but not TA, 
we documented morphological and molecular evidence of partial denervation (e.g. terminal axonal sprouting 
and induction of the fetal AChRγ -subunit mRNA, respectively). Both muscles also displayed a mixture of fiber 
loss and mild atrophy, but minimal changes in fiber-type composition. These results were consistent with a role 
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for ERK1/2 in the maintenance of muscle mass, but not of the fast-twitch fiber phenotype, and demonstrated 
an important role for ERK1/2 in keeping the structural integrity of the mature NMJ in vivo. In our previous 
experiments10, we did not study the effects of lack of ERK1/2 on predominantly slow-twitch muscles, nor could 
we discern whether the phenotypes observed were primarily derived from synaptic or extrasynaptic functions of 
myofiber ERK1/2.
Here we focused our studies mainly on the soleus (SOL), a prototypical slow-twitch muscle, which unlike the 
STN and TA has abundant type 1 fibers, rich in mitochondria and highly dependent on oxidative metabolism11,12. 
ERKs are most active in type 1 fibers9. Thus it is important to determine the consequences that develop for these 
cells when these kinases are absent. We found that fiber morphology in mutant SOL in young adults (9–14 weeks 
of age) was much more affected than in either the STN or TA. Type 1 fibers in the SOL, in particular, were very 
atrophied at this age. We also found fragmented NMJs with low levels of AChR expression and evidence of exten-
sive denervation in these muscles. Moreover, defective mitochondrial function and/or biogenesis were part of the 
phenotype in mutant SOL in young adults. The striking severity and rapidity in the development of this pheno-
type facilitated the examination of muscles at different postnatal times. While, at three weeks after birth, control 
and mutant muscles were similar in fiber morphology, we found evidence of nascent denervation and a defective 
γ /ε -AChR subunit switch predominantly at NMJs on type 1 fibers. This suggests synaptic instability precedes 
extrasynaptic changes in myofibers lacking ERK1/2 in SOL. These results also support the notion that the synapse 
is a primary subcellular target for muscle ERK1/2 function in vivo.
Results
We combined a germ line Erk1 mutation with conditional Cre-loxP Erk2 inactivation in skeletal muscle to pro-
duce mice lacking both ERK1/2 selectively in skeletal myofibers (hereafter DKO mice). Cre was driven by the 
human α -skeletal muscle actin (Hsa) promoter, which is expressed only in myofibers, and not in other cells in the 
muscle tissue, starting around embryonic day 9.513–15. In the fast-twitch STN and TA we measured a ~90% reduc-
tion in ERK2 levels in mutants relative to control10. In DKO SOL, ERK2 levels were ~70% lower than in control 
(Fig. 1). In our initial characterization of these animals, we found they could be divided into two groups according 
to how fast they lost weight10. “Severe” animals lost weight quickly starting at about 7 weeks of age, while “mild” 
double mutants were able to keep their weight at that age but clearly failed to keep up with controls. Severe and 
mild DKO mice were generated at about 1:1 ratio, and displayed similar signs of muscle weakness (e.g. forelimb 
grip strength normalized to body weight) between 7–11 weeks of age10. The difference in weight progression 
between mild and severe DKO mice seemed unexplained by lower ERK2 in the latter, as residual ERK2 levels 
were similar between mild and severe DKO muscle (p = 0.32; Fig. 1). We do not know the reason for these mild/
severe differences but we propose they could be related to undetermined differences in genetic background. For 
the experiments below all the mutant mice that were 9 weeks or older were DKO mild, while those younger could 
not be distinguished as mild or severe before that age.
Effects on Fiber Number, Fiber Type Composition, and Preferential Atrophy of Type 1 Fibers. 
We cut frozen cross sections of SOL muscles from young adults (9–14 weeks old), and stained for dystrophin to 
mark the cell surface of the myofibers. While control SOL showed a homogenous distribution of fiber sizes, SOL 
muscle from DKO mice showed a clear reduction in muscle cross-sectional area suggesting fiber loss, with many 
Figure 1. ERK1/2 levels in control and DKO 9 week-old SOL. (a) Lysates from 3 separate SOL muscles from 
control, DKO mild and DKO severe were probed simultaneously for total ERK1/2 (tERK1/2) and for α -tubulin 
(α -Tub) to check for loading differences. In DKO muscle, ERK1 was completely eliminated and ERK2 was 
sharply reduced. (b) Normalization to α -Tub showed ERK2 levels were 0.30 ± 0.08 –fold and 0.23 ± 0.08 –fold 
control levels in DKO mild mice and in DKO severe mice, respectively. Values are mean + SD. **p < 0.01; NS, 
no significant.
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atrophied and hypertrophied fibers among the remaining myofibers (Fig. 2a). Although we detected fiber loss 
in DKO STN, such dramatic heterogeneity in fiber size was not observed in DKO STN or TA of the same age10. 
Next, we used immunostaining for the four canonical adult myosin heavy chains (MyHC types 1, 2A, 2B and 
2X)11 at different postnatal times: 3 (weaning), 5–6, 9, and 14 weeks of age. We followed a protocol that allowed 
simultaneous staining for all isoforms on the same section; types 1, 2A and 2B by positive staining, 2X by the 
absence of any staining16. Muscles in DKO weanlings appeared similar to controls in cross-sectional area and 
variability of fiber size (Supplementary Fig. 1), while in young adult DKO, type 1 fibers, in particular, were very 
atrophied (Fig. 2b,c). We then determined fiber numbers and fiber type composition in controls and DKOs from 
such stained cross sections. DKO SOL had slightly fewer fibers than control at weaning, but by 5 weeks of age, 
DKO SOL had many fewer fibers than control, reaching a ~40% reduction relative to control by 9 weeks (Fig. 2d). 
In 9–14 week-old young adults, controls had 835.8 ± 40.2 fibers on average (n = 4), while DKOs had 493.8 ± 44.3 
fibers (n = 5). This was a statistically significant reduction (p = 0.0007; t-test). These data suggested a clear post-
natal loss of fibers in the DKO SOL. The inset in Fig. 2d shows representative muscles for control and DKO at 
14 weeks and illustrates the extent of wasting at the whole muscle level. Muscle wet weight was consistent with 
Figure 2. Dramatic wasting of the young adult DKO SOL. (a) Cross sections of SOL from 9-week-old 
control and DKO females stained for dystrophin. Notice reduction in muscle cross-sectional area and dramatic 
heterogeneity of fiber size in the DKO SOL. Scale bar: 200 μ m. (b) Simultaneous immunostaining for MyHC 
types in SOL. Types 1, 2A, and 2B were positively stained, while type 2X was identified by the absence of 
staining. At 3 weeks, control and DKO SOL were similar in cross sectional area. Note small size of most type 1 
fibers in 9 week DKO. Scale bar: 200 μ m. (c) Higher magnification field for MyHC staining at 9 weeks. Examples 
of hybrid (H, 1 + 2A) fibers are highlighted with asterisks (*). Scale bar: 50 μ m. (d) Fiber numbers per cross 
section in control and DKO SOL at different postnatal times. N = 2–3 muscles per time point/genotype. Values 
are mean ± SD. Inset shows control (top) and DKO (bottom) representative muscles at 14-weeks (females). 
Scale bar: 2 mm. (e) Fiber type composition in control (CON) and DKO SOL at different postnatal times. 
N = 2–3 muscles per time point/genotype. Values are mean + SD.
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the above data as 14 week-old DKO SOL weighed ~40% less than control (DKO: 9.45 ± 1.21 mg; n = 4 muscles. 
Control: 14.72 ± 0.88 mg; n = 6 muscles; p = 0.007). The loss in DKO SOL mass was not simply a reflection of the 
loss of body weight10, as even after normalization to body weight, muscle weights remained lower in mutants than 
in controls (DKO: 0.44 ± 0.07 mg/g, n = 2 animals. Control: 0.58 ± 0.05 mg/g, n = 3 animals).
Interestingly, fiber type composition remained largely unchanged, with relative percentages of the most 
abundant fiber types (1, 2A and 2X) in mutant muscle being similar to those in age-matched control (Fig. 2e). 
Nevertheless, some changes in fiber composition that affected rare fiber types in the SOL were observed in DKO 
muscle. Thus, type 2B fibers, which were a very variable ~4% in control at 3 weeks, were absent in DKO at this 
age. However, type 2B fibers in control SOL reached the same very low levels in DKO by 5–6 weeks (Fig. 2e). 
Type1 + 2A hybrid fibers (Fig. 2c), which were less than ~0.2% in control, were present at ~5% at 9 weeks or later 
(Fig. 2e). When fiber counts were sorted by fiber type (Supplementary Fig. 2), type 1, 2A and 2X fibers in young 
adult (9–14 week-old) DKO were all reduced relative to age-matched control. Thus, cell loss affected all major 
fiber types and started after 3 weeks of age. At 9 weeks, we also analyzed fiber type composition by measuring 
mRNA levels for the genes encoding the myosin heavy chains (Myh1, Myh2, Myh4, Myh7)11 by real-time PCR. In 
DKO SOL, a statistically significant ~3-fold reduction of Myh7 (type 1) mRNA (p = 0.004), and a tendency toward 
reduction in Myh4 (type 2B) transcript (Fig. 3a) were observed. In the fast-twitch DKO STN and TA muscles, no 
statistically significant changes in expression of myosin heavy chain genes were detected, even though a tendency 
toward decrease was seen for Myh7 (Supplementary Fig. 3). Our results are better interpreted in the context of 
the normal levels of Myh7 expression in each of the muscle groups. Myh7 expression in control SOL was ~30-fold 
higher than in STN and TA (Supplementary Fig. 3). Thus, because of higher control levels, the 70% reduction in 
Myh7 mRNA expression in DKO SOL is much more meaningful than a similar tendency in TA or STN, where 
Myh7 expression is normally very low (i.e. there are very few type 1 fibers in these muscles). The reduction in 
Myh7 mRNA levels in the DKO SOL was associated with the preferential atrophy of these fibers (Fig. 2b,c) and 
not with fiber switching, as relative fiber type composition was largely similar between control and DKO SOL 
(Fig. 2e). Indeed, a histogram of fiber areas showed that ~70% of type 1 fibers in 14 week DKO SOL were smaller 
than 750 μ m2, while almost no fibers that small were found in controls (Fig. 3b). On the other hand, very small 
(< 750 μ m2) and very large (> 3000 μ m2) 2A and 2X fibers were much more abundant in DKO SOL than in control 
(Fig. 3c,d), suggesting that these fast-twitch fibers undergo both atrophy and hypertrophy. At 5–6 weeks, average 
area for all major fiber types was statistically larger in DKO SOL than in control (Supplementary Fig. 4). This 
Figure 3. Relative Myh mRNA expression and area distribution by fiber type. (a) Analysis of real-time PCR for 
MyHC genes at 9 weeks. N = 6 per genotype. Values are mean + SEM. **p < 0.01, t-test v. control. (b,c,d) Fiber area 
data for 14-week-old animals were grouped in 250 μ m2 bins along the X axis and the percentages of fibers in those 
bins were plotted on the Y axis. In the DKO SOL, type 1 fibers atrophied, while types 2A and 2X both atrophied 
and hypertrophied. N = 2, control muscles; 3, DKO muscles. Type 1 fibers scored: 675 control, 476 DKO. Type 2A 
fibers scored: 914 control, 592 DKO. Type 2X fibers scored: 232 control, 66 DKO. Distributions were compared 
statistically using the Wilconox rank sum test. P < 3.2 × 10−5 control v. DKO.
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result suggests that fibers in DKO SOL may hypertrophy before atrophy ensues, perhaps as a compensation for 
fiber loss.
We also examined type 1 fiber area in two fast-twitch muscles, STN and extensor digitorum longus (EDL) 
(Supplementary Fig. 5). Type 1 fibers are present at very low numbers in these muscles. Atrophy of type 1 fib-
ers was evident in the 14-week DKO STN as fibers > 300 μ m2 in area were absent, while present in control. In 
14-week DKO EDL, type 1 fiber atrophy was less robust yet statistically present as average fiber area was ~25% 
lower than control (DKO: 132.17 ± 8.87 μ m2, n = 51 fibers, 4 mice. Control: 178.50 ± 12.18 μ m2, n = 42 fibers, 4 
mice; p = 0.004, t-test; p = 0.008, Wilconox rank sum test). Thus, atrophy of type 1 fibers occurred in all muscles 
studied.
Effects on Synapse Morphology and Denervation-Related Molecular Markers. As in STN and 
TA10, NMJs with signs of fragmentation and diminished AChR expression could be found in young adult DKO 
SOL (Fig. 4a,b). Using real-time PCR, we found a ~5-fold reduction in AChRε mRNA in DKO SOL relative to 
control (inset Fig. 4c; p = 0.000007). There was morphological and molecular evidence of partial denervation in 
the DKO SOL in young adults (Fig. 4). Most notably, there was a ~60-fold increase in mRNA for Chrng, the gene 
encoding the distinctive γ -subunit of the fetal AChR17 (p = 0.00014), and a ~20-fold induction for Runx1 mRNA 
(p = 0.00004), a transcription factor highly induced in skeletal muscle after denervation18,19. Furthermore, the 
myogenic factor myogenin (Myog), the embryonic myosin isoform (Myh3), and the agrin-transducing receptor 
Musk, all known markers of denervation19–21, were also elevated between ~3- and 6-fold over control (p = 0.00003, 
0.013, 0.0004, respectively) (Fig. 4c).
Denervation in the adult induces replacement of the AChRε subunit with the AChRγ subunit at synaptic 
sites22. Staining for AChRγ with subunit-specific antibodies23 on cross sections of 14 week-old muscle showed 
that ~90% of BTX-labeled synaptic sites incorporated these fetal receptors in DKO SOL (Fig. 5). Absence of 
co-staining for the presynaptic marker SV2 suggested denervation at ~70% of these sites (Fig. 5). Even most of 
the SV2+ NMJs were also AChRγ + (Fig. 5b). Staining of serial sections with AChRε subunit-specific antibodies23 
was consistent with the AChRγ staining, and directly showed that only ~10% of synaptic sites were AChRε + /
SV2+ in DKO SOL while over 90% were so in control (Fig. 5b).
Thus, by 14 weeks in DKO SOL, most NMJs appeared denervated and had γ -subunit-containing AChRs. The 
presence of type 1 + 2A hybrid fibers in DKO SOL of young adults (Fig. 2e, above), and the selective reduction of 
Myh7 mRNA (Fig. 3a) were also consistent with denervation/re-innervation cycles occurring in this muscle24–26. 
Thus, DKO SOL in young adults showed signs of marked NMJ instability that included reduction of AChRε 
expression and loss of nerve-muscle contact.
Mitochondrial Alterations. Given that over 70% of myofibers in the SOL are metabolically oxidative (type 1 
and type 2A), we assessed oxidative capacity on cross sections of 9–14 week-old SOL by cytochemical staining 
for cytochrome oxidase (COX) and succinate dehydrogenase (SDH)27. These enzymes showed much reduced 
activity in DKO SOL relative to control at this age (Fig. 6a), consistent with diminished mitochondrial function. 
Next, we used real-time PCR to measure mRNA levels of the regulators of mitochondrial biogenesis peroxi-
some proliferator-activated receptor γ coactivator 1α (PGC-1α28) and PGC-1β29, the mitochondrial fusion/fission 
markers mitofusin 1 and 2 (Mfn1, Mfn2), dynamin-related protein 1 (Drp1)30, and the mitochondrial markers 
BCL2/Adenovirus E1B 19 kDa interacting protein 3 (Bnip3), cytochrome b (Cytob), and uncoupling protein 3 
(Ucp3). While Ucp3 tended to decrease and Drp1 did not change, we found statistically significant ~2-fold reduc-
tions in mRNA for PGC-1β, Mfn1 and Mfn2, Bnip3, Cytob and PGC-1α (p values = 0.005, 0.02, 0.009, 0.001, 
0.0003, 0.01, respectively) (Fig. 6b). A ~3-fold reduction in PGC-1α protein was also detected in the DKO SOL 
(p = 0.01; Fig. 6c). In contrast, PGC-1α mRNA in the fast twitch STN and TA muscles were not different between 
mutant and control at the same age (Supplementary Fig. 6). SOD2, a mitochondrial protein that is a direct down-
stream target of PCG-1α regulation31, was reduced ~40% in DKO SOL (p = 0.009; Fig. 6c). Together, these results 
suggest that absence of muscle ERK1/2 specifically in the SOL leads to reduced mitochondrial biogenesis, which 
may account, at least in part, for the lower oxidative capacity reflected by the decrease in COX and SDH activities. 
These mitochondrial alterations were also in keeping with the ample evidence of denervation found in these 
muscles26,32.
Early Events That Precede Fiber Atrophy And Loss. To search for potential mechanisms that drive the 
phenotype, we analyzed gene expression at 3 weeks. We chose this time point because fiber loss and atrophy were 
largely absent (Fig. 2b,d and Supplementary Fig. 1). We specifically focused on genes whose expression levels were 
altered at 9 weeks: Myh7 (Fig. 3a), the denervation/synaptic markers (Fig. 4c) and mitochondrial genes (Fig. 6b) 
as well as key genes for autophagy and ubiquitin-proteasome-mediated proteolysis, since these are primary mech-
anisms mediating muscle atrophy in most muscle wasting situations33,34. Only expression of Chrne (decreased by 
~2-fold; p = 0.0006), Chrng, and Runx1 (increased by ~3- and ~1.3-fold, respectively; p = 0.004 and 0.02, respec-
tively) were statistically altered at this early time (Fig. 7a). Neither Myh7, or the other MyHC genes (Fig. 7b), nor 
the mitochondrial- or muscle atrophy-related genes (Fig. 7c) exhibited differences at the mRNA level between 
DKO and control SOL at this early age. These results suggested that synaptic alterations that may lead to dener-
vation preceded all other phenotypic changes in DKO SOL. To further support this conclusion, we co-stained 
for AChRγ , SV2 and BTX to check for the presence of synapses expressing the fetal form of the AChR (Fig. 8). 
Control muscles at 3 weeks had a very small and variable fraction of AChRγ + /SV2+ synapses (2.7 ± 3.4%), con-
sistent with previous reports that showed that AChRγ persists in some NMJs about a week longer in normal SOL 
than in fast-twitch muscles35. However, in DKO muscle 38.5 ± 8.1% of NMJs were AChRγ + /SV2+ at 3 weeks 
of age (Fig. 8a,b). This ~10-fold difference in AChRγ + /SV2+ NMJs between DKO and control was statistically 
significant (p = 0.002). Consistent with the slight but statistically significant increase in Runx1 mRNA (Fig. 7) 
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and the presence of a few type1 + 2A hybrid fibers in the DKO SOL at 3 weeks (Fig. 2e), a small, highly-variable 
fraction of endplates (3.4 ± 3.7%) appeared denervated as they lacked SV2 staining and were AChRγ + (Fig. 8b). 
AChRγ + /SV2- synaptic sites were not detected in control muscles (Fig. 8b). Staining for AChRε at this early age 
showed a statistically significant increase in AChRε -/SV2+ NMJs in DKO muscle relative to control (13.4 ± 2.4% 
and 4.2 ± 2.2%, respectively; p = 0.008) and a corresponding reduction in AChRε + /SV2+ endplates (89.4 ± 4.5% 
control, 79.6 ± 5.2% DKO) that almost reached statistical significance (p = 0.07) (Fig. 8c and d). Because the frac-
tion of AChRγ + /SV2+ NMJs (38.5 ± 8.1%) is larger than the fraction of AChRε -/SV2+ NMJs (13.4 ± 2.4%), it 
is likely that many of the AChRε + /SV2+ junctions are also AChRγ + in weanling DKO muscles. In this context, 
it should be mentioned that extrasynaptic background staining tended to be higher, particularly in DKO muscle, 
when staining for AChRε than when staining for AChRγ (Figs 5 and 8), which made the quantification more 
challenging for the former than for the latter. We next stained simultaneously for AChRγ , positively for MyHCs 
1 and 2A, negatively for 2X + 2B, and added BTX to try to determine if AChRγ -containing NMJs preferentially 
Figure 4. Synaptic alterations in young adult DKO SOL. (a) Confocal “en face” view of a 9-week control 
NMJ labeled with fluorescein-BTX to mark AChRs (a’) and with antibodies to synaptophysin, followed by 
rhodamine-conjugated secondary antibodies, to label nerve terminals (a”). Long, continuous AChR domains 
are tightly apposed by nerve terminals. (b) Confocal “en face” view of a fragmented NMJ in 9-week DKO muscle 
with small, mostly round, dim AChR domains (b’) variably apposed by nerve terminal staining (b”). Arrow: Side 
view of an aneural synaptic site with very weak AChR staining and axonal retraction bulb. Scale bar: 10 μ m.  
(c) Real-time PCR of mRNA for denervation and postsynaptic genes at 9 weeks. Chrne was reduced by ~5-fold  
(inset), while the other mRNAs were increased between 3- and 60-fold. N = 6 per genotype. Values are 
mean + SEM. **p < 0.01; *p < 0.05; t-test v. control.
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localized to a particular fiber type at this early time in DKO SOL. We found that 71% of AChRγ + endplates 
occurred on type 1 fibers (40/56 endplates, n = 3 muscles), while 25% and 2% of endplates containing this subunit 
were found on type 2A and 2X/2B fibers, respectively (Fig. 9). Thus despite higher proportion of type 2 fibers in 
SOL (Fig. 2e), synapses on type 1 fibers were much more susceptible to alteration following ERK1/2 deficiency 
than those on type 2 fibers. Taken together, these results strongly suggest that a defective γ /ε -AChR switch and 
perhaps even loss of synaptic connectivity, particularly on type 1 fibers, are early events in the development of the 
wasting phenotype in DKO SOL.
Discussion
The analysis of the slow-twitch SOL muscles in mice lacking ERK1/2 in myofibers reveals that these kinases 
critically regulate type 1 fiber size in vivo. This regulation may extend to type 1 fibers in many muscle groups as 
their atrophy was detected in fast-twitch STN and EDL. ERK1/2 also appears to control the γ /ε -AChR switch at 
maturing NMJs in SOL, whose impairment precedes any other alterations.
ERK phosphorylation levels in adult rat skeletal muscle fibers are sensitive to the firing pattern of the moto-
neurons that innervate them. In particular, a low frequency/high amount impulse pattern (20 Hz), typical of slow 
motoneurons that innervate type 1 fibers, elicited the highest increase in ERK phosphorylation when applied to 
adult rat SOL muscle9. Firing patterns more similar to those for type 2B or type 2A motor units failed to stimulate, 
or more modestly induced ERK activation, respectively9. These results predict that removal of ERK from skeletal 
muscle fibers should more dramatically affect the type 1 muscle fibers. Our results in mouse SOL are consistent 
with this prediction and support the notion that ERK1/2 play a critical role in type 1 fibers. Although type 2 fibers 
are also affected as they undergo both atrophy and hypertrophy (Fig. 3), the dramatic myofiber wasting in young 
adult DKO SOL directly correlates with its higher content of type 1 fibers (~30%, this work and others (e.g.16)) 
relative to the previously examined STN and TA10. Type 1 fiber atrophy was also detected in fast twitch muscles. 
In DKO STN there was a clear absence of large type 1 fibers, while in the EDL the atrophy was less robust but 
present statistically. The difficulty of detecting robust atrophy in EDL might be related to the already small size 
of its few slow fibers. Indeed, type 1 fibers in control EDL were on average as small as the most atrophied fibers 
in the DKO SOL (Fig. 3b). In addition, it is known that type 1 fibers in the rat EDL, for example, are resistant to 
Figure 5. AChRγ/ε staining in 14 week SOL cross sections. (a) Control pictures show 3 innervated NMJs 
(SV2+ ) that failed to label for AChRγ (AChRγ -). DKO pictures show 5 AChRγ + /SV2- synaptic sites. Scale bar: 
50 μ m. (b) Quantification for AChRγ /SV2/BTX staining. Values are mean ± (SD). N = 2 control muscles, 74 
endplates; 3 DKO muscles, 100 endplates. (c) Control pictures show 3 innervated NMJs (SV2+ ) that label for 
AChRε (AChRε + ). DKO pictures show 5 synaptic sites, two strongly positive for BTX and 3 with weak BTX 
staining. All 5 sites lack both AChRε and SV2 staining. Scale bars: 50 μ m. (d) Quantification for AChRε /SV2/
BTX staining. Values are mean ± (SD). N = 2 control muscles, 77 endplates; 3 DKO muscles, 77 endplates.
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denervation-induced atrophy, while they are very sensitive in the SOL24. Rat type 1 fibers in SOL are ~3 times 
larger than in the EDL16. Thus, it is possible that small type 1 fibers for some reason are much less sensitive to the 
lack of ERK1/2 than large type 1 fibers.
Since our DKO mice lack ERK1 in all cells, including motoneurons, it is reasonable to ask whether the absence 
of ERK1 in motoneurons lowers the threshold for the defects in NMJ maturation we observed. This does not 
appear to be the case as SOL morphology and relative mRNA levels of synaptic/denervation markers in young 
adult Erk1−/− mice were similar to control (Supplementary Fig. 7).
A primary role of myofiber ERK1/2 in DKO SOL seems to be synaptic rather than extrasynaptic since a defec-
tive γ /ε -AChR subunit switch, largely confined, but not exclusive to NMJs on type 1 fibers, preceded fiber loss and 
atrophy. Chrne−/− mice survive development and go normally through some milestones of postnatal synaptic mat-
uration such as synapse elimination3,4. However, their NMJs, which retain the fetal AChRγ subunit, have a much 
lower density of AChRs and show structural postnatal abnormalities such as fragmentation4,5. Chrne−/− mice 
also develop muscle atrophy, show a fast-to-slow fiber type transition in both fast- and slow-twitch muscles36, 
and fail to live past 14 weeks. These results indicate that ε -containing AChRs play a structural role in the normal 
maturation of the NMJ, and that a defective γ /ε -switch leads to alterations in the maintenance of muscle fibers. Thus 
the defective γ /ε -switch may be a contributor to the striking wasting of the SOL muscle in ERK1/2 deficient mice. 
A reduction of AChRε expression is common to the STN, TA10, and SOL (Fig. 3c) in young adult DKO animals. 
These reductions are averages for the whole muscle, and it is possible they are larger at some synaptic sites than at 
others, as suggested by the AChRγ /ε staining (Fig. 4). Specific molecular mechanisms by which ERK1/2 upreg-
ulate AChRε expression in vivo remain to be determined, although transcriptional regulation is likely one of 
them37,38. As in the Chrne−/− mice, induction of AChRγ expression in ERK1/2-deficient fibers may arise as com-
pensation to the reduction in AChRε and/or after denervation. Alternatively, ERK1/2 may be necessary to repress 
AChRγ expression, at least in type 1, and perhaps some type 2A fibers.
There are some differences between the ERK1/2-deficient and Chrne−/− SOL that suggest that processes other 
than the defective γ /ε -AChR switch also contribute to the phenotype of the former. Neither fiber loss, in general, 
nor atrophy of type 1 fibers or reduction of Myh7 expression, in particular, were reported in Chrne−/− SOL at least 
up to 9 weeks of age36. Moreover, although physiological evidence3 and presence of terminal axonal sprouts4 sug-
gested some degree of paralysis or partial denervation, it is unclear if anatomical denervation actually occurs at 
AChRε -less NMJs. One could speculate that had the Chrne−/− mice survived longer than the 2–3 months of their 
average lifespan, clearer signs of denervation might have been detected in their SOL. In DKO SOL, denervation 
extended to ~70% of synaptic sites by 14 weeks of age (Fig. 5). This denervation is myogenic, and not neurogenic, 
in origin, as no changes in activate or total ERK2 levels were detected in spinal cord of DKO mice10. This finding is 
consistent with the lack of Cre expression in spinal cord for the human α -skeletal actin-Cre driver used to generate 
these mice (http://www.informatics.jax.org/recombinase/specificity?id= MGI:2447635&systemKey= 4856356). 
Figure 6. Mitochondrial phenotype in young adult DKO SOL. (a) Reduced cytochrome oxidase (COX) and 
succinate dehydrogenase (SDH) activity on control and DKO SOL cross sections of 9 week mice. Scale bars: Top 
row pictures 200 μ m; middle and bottom row pictures 50 μ m. N = 2 per genotype. (b) Real-time PCR for mRNA 
of mitochondrial markers on 9 week SOL. N = 6 per genotype. Values are mean + SEM. *p < 0.05; **p < 0.01; 
t-test v. control. (c) Top 2 Western blots illustrate active (pERK1/2) and total (tERK1/2) ERK protein levels in 
9-week control and DKO SOL. The same lysates were probed in separate blots for PGC-1α (middle blot) and 
SOD2 (bottom blot). Loading of PGC-1α and SOD2 blots was assayed with α -tubulin antibody (α -Tub, bottom 
blot). (d) PCG-1α and SOD2 quantification. N = 3 per genotype. Values are mean + SD. *p < 0.05; **p < 0.01; 
t-test v. control.
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The precise mechanism(s) responsible for denervation is unclear, and it is possible that different mechanisms 
operate on different fiber types depending on their activity level. Fiber loss, which occurred mainly between 3–6 
weeks (Fig. 2d), and which appeared fiber-type unspecific (Supplementary Fig. 2), may have produced remod-
eling of motor unit size in the whole mutant SOL. Moreover, the longer open times of the γ -containing AChR2 
might lead to increased local postsynaptic Ca2+, which might cause endplate degeneration and induction of 
slow-channel-like myasthenia39. Perhaps in the absence of ERK1/2, the tonic pattern of activity of type1 fibers 
and certain types of 2A fibers makes them more susceptible to synaptic Ca2+ overload than the phasic firing 
pattern of type 2B fibers. Alternatively or in addition, fiber-wide activity-dependent metabolic damage due to 
mitochondrial alterations or other general defects in post-weaning maturation may be responsible for the persis-
tent denervation in young adult DKO SOL. Alterations in mitochondrial biogenesis and function were suggested 
by the reduction in COX and SDH activities and in mitochondrial markers, particularly PGC1-α (Fig. 6). Lack 
of PCG-1α reduces mitochondrial biogenesis40, but it also appears to modulate denervation-induced mitophagy, 
at least in fast-twitch muscles41. Further experiments are required to investigate a possible signaling link between 
ERK1/2 and PGC-1α , and its potential impact on mitochondrial dynamics. The mitochondrial alterations might 
trigger and/or increase the severity of denervation-induced wasting in ERK1/2-deficient SOL. To our knowledge, 
mitochondrial phenotypes have not been studied in Chrne−/− mice. It will be interesting to do so to compare and 
contrast with our ERK1/2-deficient mice.
Figure 7. Relative mRNA expression at 3 weeks. (a) Real-time PCR of mRNA for denervation and 
postsynaptic genes at 3 weeks. Chrne was reduced by ~2-fold, while Chrng and Runx1 were increased by ~3- 
and 1.3-fold, respectively. (b) Real-time PCR of mRNA for MyHC genes. (c) Real-time PCR of mRNA for 
mitochondrial (Pgc-1α – Mfn2) and protein degradation genes (Sqstm1 (p62), Atrogin1 and Murf1). None 
of these genes showed any expression changes with genotype at this age. N = 6 control, 5 DKO. Values are 
mean + SEM. **p < 0.01; *p < 0.05; t-test v. control.
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At 3 weeks we also saw a lack of 2B fibers in the DKO SOL (Fig. 2). These fibers were a small, very variable 
minority in control muscle at this age that in any event, were normally reduced to the levels present in DKO mus-
cle by 5–6 weeks. Although this was an early event, it is unlikely that it is a major driver of the wasting of the DKO 
SOL as these fibers constitute such a minor component of the normal SOL. Furthermore, expression of Myh4 
mRNA (Supplementary Fig. 3) and 2B proportions by immunostaining, even in predominantly fast-twitch STN 
and TA muscles, are not affected by the lack of myofiber ERK1/210.
Induction of AChRγ specifically in type 1 fibers is a common feature of many human neuromuscular disor-
ders42. Although simple neurogenic denervation is the presumed main mechanism underlying this effect in most 
-but not all- cases, it is unclear why it is restricted to type 1 fibers. Given our results in mice, downregulation of 
myofiber ERK1/2 signaling might be an underappreciated mechanism driving this phenomenon.
Materials and Methods
Ethics Statement. Care and treatment of all animals followed the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee of 
Texas A&M University under animal use protocols 2012-168 and 2014-060.
Mice and Genotyping. Generation and genotyping of mice were described previously10. Cre was driven 
by the human α -skeletal muscle actin (Hsa) promoter. Mice deficient in germ line ERK1 and myofiber ERK2 
came from the following cross: Hsa-Cre+/−; Erk1+/−; Erk2f/f x Hsa-Cre−/−; Erk1−/−; Erk2f/f. The genotype of 
mutant animals (referred in the text as DKO mice) was Hsa-Cre+/−; Erk1−/−; Erk2f/f. The genotype of controls was 
Hsa-Cre−/−; Erk1+/?; Erk2f/f. Males and females of all genotypes were used in all experiments.
Myofiber Morphological Analysis and Typing. Mice were euthanized by CO2 and muscles were imme-
diately dissected. Muscles were embedded in tissue-tek (OCT, Sakura, Torrance, CA) within a plastic mold, frozen 
in liquid N2-cooled isopentane and stored at − 80 °C until use. Dystrophin staining of transverse frozen sec-
tions was performed essentially as previously described except that sections were not fixed43. The same protocol 
Figure 8. AChRγ/ε staining in 3 week SOL cross sections. (a) Control pictures show 7 innervated NMJs (SV2+ ) 
that were AChRγ -. DKO pictures show 4 AChRγ + /SV2+ NMJs in focus. Scale bar: 50 μ m. (b) Quantification for 
AChRγ /SV2/BTX staining. Values are mean ± (SD). N = 3 control muscles, 139 endplates; 3 DKO muscles, 148 
endplates. (c) Control pictures show 5 innervated NMJs (SV2+ ) that label for AChRε (AChRε + ). DKO pictures 
show 4 synaptic sites (arrowheads) where AChRε staining is not above extrasynaptic background levels on same 
fiber (AChRε -). The other endplates are AChRε + . Scale bar: 50 μ m. (d) Quantification for AChRε /SV2/BTX 
staining. Values are mean ± (SD). N = 3 control muscles, 145 endplates; 3 DKO muscles, 109 endplates.
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was followed for laminin staining with a chicken polyclonal Ab IgY primary at 1:400, and a goat anti-chicken 
IgY H + L AlexaFluor 647 secondary at 1:500 (Abcam, Cambridge, MA). Fiber typing was done by multicolor 
immunofluorescence staining16 with some modifications. The same primary myosin heavy chain antibodies 
(Developmental Studies Hybridoma Bank, Iowa City, Iowa) at the previously reported dilutions were used to pos-
itively stain for type 1 (BA-F8), type 2A (SC-71), and type 2B (BF-F3). Type 2X fibers were those that remained 
unstained. Primary antibodies were visualized simultaneously with secondary antibodies (ThermoFisher 
Scientific/LifeTechnologies, Grand Island, New York) at 1:500 dilution: BA-F8 with Alexa-647 goat anti-mouse 
IgG2b; SC-71 with Alexa-488 goat anti-mouse IgG1; BF-F3 with Alexa-568 goat anti-mouse IgM. For fiber typ-
ing of individual cross sections, 10X images for each of the three fluorescence channels were taken with a Nikon 
wide-field E1000 microscope (Nikon Inc., Melville, New York), then merged and pseudocolored in Metamorph 
(Molecular Devices, Sunnyvale, California). To reconstruct an entire muscle cross section, the above overlapping 
images were assembled as a montage in Photoshop (Adobe Systems Inc., San Jose, CA). Individual fluorescence 
channels from these composites were counted to obtain the number of fibers of each type within one entire cross 
section. All fibers within the composites were counted. These numbers were used to derive the total number of 
fibers and relative fiber type composition. Fiber area was also derived from these images by first manually draw-
ing a border around stained fibers within a channel using the trace region tool in Metamorph. These regions of 
interest were thresholded and analyzed with the integrated morphometric analysis tool to determine their area. 
As these images overlapped to cover the entire cross section, care was taken not to measure the same fibers more 
than once. At least 60% of fibers per muscle were processed this way for all but the 5–6 week controls, where at 
least 40% were so measured. Replicates per muscle per genotype were averaged for final quantification.
AChRγ/ε Staining and Quantification. Rabbit antibodies to AChRγ and AChRε were a kind gift of Dr. 
Norihiro Yumoto (New York University) and were previously characterized23. Immunostaining of transverse 
serial sections was performed as described above with the following modifications: Blocking and antibody incu-
bation for AChRγ experiments were performed in 10% normal goat serum in PBS + 0.1% Triton X-100, whereas 
for AChRε experiments they were blocked and incubated in 5% non-fat dry milk in PBS. These antibodies were 
visualized with rhodamine-goat anti-rabbit IgG (Jackson Immunoresearch Laboratories Inc., West Grove, PA) at 
1:400. All AChRs were labeled with fluorescein-α -BTX, LifeTechnologies) at 1:3000. Nerve terminals were labe-
led with mouse monoclonal antibody to SV2 (Developmental Studies Hybridoma Bank) at 1:10, visualized with 
Alexa-647 goat anti-mouse IgG (LifeTechnologies) at 1:400. For quantification, 10 images per slide were taken 
for each separate channel per muscle at 20X magnification with a wide-field microscope (Nikon). BTX-positive 
synaptic sites were scored for AChR subunit and SV2 staining. Positive staining was that above extrasynaptic 
background on same fiber. Although we noticed differences in intensity of AChRγ /ε staining among synaptic 
sites, no efforts were made to quantify these levels separately. For AChRγ and type 1/2A MyHC co-staining, sec-
tions remained unfixed throughout. AChRγ , type 1 and type 2A MyHCs were visualized with the same secondary 
Figure 9. AChRγ staining preferentially at NMJs on type 1 fibers in 3-week-old DKO SOL. (a) Four NMJs 
labeled with fluorescein BTX, three on type 2A fibers and one (yellow arrowhead) on a type 1 fiber. Only the 
latter is AChRγ + . BTX and type 2A staining were visualized in fluorescein channel; AChRγ visualized in 
rhodamine channel; type 1 visualized in Cy5 (647 nm) channel. Scale bar: 50 μ m. (b) Quantification of AChRγ + 
NMJs by fiber types in DKO SOL. N = 3 muscles; 56 NMJs.
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antibodies used above. Fluorescein-BTX was included to mark synaptic sites. Thus type 2A and BTX staining 
were both observed under fluorescein optics.
Whole Mount Staining and Confocal Microscopy. Visualization of NMJs by whole mount and confocal 
microscopy was done as described previously10.
Western Blotting. Muscle lysates were prepared in 25 mM Tris pH 7.4, 95 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1% SDS, 10% Protease Inhibitor Cocktail (P8340, Sigma-Aldrich, St. Louis, MO), 5 mM NaF, 2 mM 
Na3VO4, 2.5 mM Na4P2O7. Protein analysis by western blotting was done as described previously10, except 30 μ g 
of total lysate per sample was used. The antibody to PGC-1α (NBP1-48320. Novus Biologicals, Littleton, CO) was 
used at 1:2000. The antibody to SOD2 (SOD-111. Stressgen Biotechnologies, Victoria, BC) was used at 1:10000.
In Situ Mitochondrial Enzyme Activity. Cytochrome oxidase (COX) and succinate dehydrogenase (SDH) 
activity on unfixed cross sections were performed as described27. Cross sections from control and DKO muscles 
were always run at the same time. Images were acquired with an EC3 camera and software (Leica Microsystems 
Inc., Buffalo Grove, IL), mounted on an Eclipse E1000 microscope (Nikon).
Real-Time Quantitative PCR. Total RNA extraction, reverse transcription, and real-time PCR were 
performed essentially as previously reported10. 200 ng of total RNA per sample was used to generate cDNA. 
Cycle threshold (Ct) values obtained for 18 S rRNA were used to equalize differences in total RNA per sample. 
Transcript level fold-change was determined by the 2−DeltaDeltaCt method44 and values were normalized to the Ct 
values obtained for control muscle for each gene. All Taqman primer sets and probes were from ThermoFisher/
Life Technologies as follows: 18 S rRNA (4333760 F), Atrogin1 (Mm00499523_m1), Bnip3 (Mm01275600_g1), 
Chrne (Mm00437411_m1), Chrng (Mm00437419_m1), Cytb (Mm04225271_g1), Drp1 (Mm01342903_m1), 
Mfn1 (Mm00612599_m1), Mfn2 (Mm00500120_m1), Murf1 (Mm01185221_m1), Musk (Mm01346929_m1), 
Myh1 (Mm01332489_m1), Myh2 (Mm01332564_m1), Myh3 (Mm01332463_m1), Myh4 (Mm01332518_m1), 
Myh7 (Mm01319006_g1), Myog (Mm00446194_m1), Pgc-1α (Mm01208835_m1), Pgc-1β (Mm00504720_m1), 
Runx1 (Mm01213404_m1), Sqstm1 (Mm00448091_m1), Ucp3 (Mm00494077_m1).
Statistical Analysis. All experiments were done at least in two biological replicas per genotype. Where bio-
logical replicas had a n ≤ 3 numerical data are expressed as mean ± SD. All real-time PCR experiments had at 
least 5 biological replicas per genotype. Numerical data for these experiments are expressed as mean ± SEM. 
Two-sample, two-tailed Student t-tests were used to compare means and were computed with Microsoft Excel 
(Microsoft Corporation, Redmond, WA). Wilcoxon rank sum test probabilities to compare distributions were 
computed at http://socr.stat.ucla.edu. Significance was set at P values of < 0.05 for* and of < 0.01 for**.
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